Progesterone Receptor Negative Recruiting Phase 1 Trials for Onalespib (DB06306)

DBCOND0038639 (Progesterone Receptor Negative)Recruiting1 IdentifierTitlePurposeDrugs
NCT02474173Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast CancerTreatment
NCT02898207Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerTreatment